Previous Article | Next Article ![]()
Mol. Cell. Biol., May 1997, 2566-2575, Vol 17, No. 5
TE Blank, MP Woods, CM Lebo, P Xin and JE Hopper
Gal4p-mediated activation of galactose gene expression in Saccharomyces
cerevisiae normally requires both galactose and the activity of Gal3p.
Recent evidence suggests that in cells exposed to galactose, Gal3p binds to
and inhibits Ga180p, an inhibitor of the transcriptional activator Gal4p.
Here, we report on the isolation and characterization of novel mutant forms
of Gal3p that can induce Gal4p activity independently of galactose. Five
mutant GAL3(c) alleles were isolated by using a selection demanding
constitutive expression of a GAL1 promoter-driven HIS3 gene. This
constitutive effect is not due to overproduction of Gal3p. The level of
constitutive GAL gene expression in cells bearing different GAL3(c) alleles
varies over more than a fourfold range and increases in response to
galactose. Utilizing glutathione S-transferase-Gal3p fusions, we determined
that the mutant Gal3p proteins show altered Gal80p-binding characteristics.
The Gal3p mutant proteins differ in their requirements for galactose and
ATP for their Gal80p-binding ability. The behavior of the novel Gal3p
proteins provides strong support for a model wherein galactose causes an
alteration in Gal3p that increases either its ability to bind to Gal80p or
its access to Gal80p. With the Gal3p-Gal80p interaction being a critical
step in the induction process, the Gal3p proteins constitute an important
new reagent for studying the induction mechanism through both in vivo and
in vitro methods.
Copyright © 1997, American Society for Microbiology
Novel Gal3 proteins showing altered Gal80p binding cause constitutive transcription of Gal4p-activated genes in Saccharomyces cerevisiae
Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey 17033, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|